Skip to search formSkip to main contentSkip to account menu

Stage IV Bladder Cancer AJCC v6

Known as: carcinoma of the bladder, stage IV, Jewett-Marshall Stage D Urinary Bladder Cancer, bladder cancer, metastatic 
Stage IV includes the following: T4b, N0, M0; Any T, N1, M0; Any T, N2 M0; Any T, N3 M0; Any T, Any N, M1. T4b: Tumor invades the pelvic wall… 
National Institutes of Health

Related topics

Related topics

11 relations
Epithelial CellsEpitheliumHematuriaMalignant Epithelial Cell

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Can urologists introduce the concept of “oligometastasis” for metastatic bladder cancer after total cystectomy?
We investigated whether the concept of oligometastasis may be introduced to the clinical management of metastatic bladder cancer… 
2014
2014
The granulocyte macrophage-colony stimulating factor surface modified MB49 bladder cancer stem cells vaccine against metastatic bladder cancer.
Review
2014
Review
2014
Optimal Treatment for Metastatic Bladder Cancer
Metastatic bladder cancer is a lethal disease. Cisplatin-based chemotherapy, including the combination regimens gemcitabine… 
Review
2010
Review
2010
[Update of the Clinical Guidelines of the European Association of Urology on muscle-invasive and metastatic bladder carcinoma].
Review
2009
Review
2009
The Ral GTPase pathway in metastatic bladder cancer: key mediator and therapeutic target.
Review
2008
Review
2008
Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways
Purpose of review An estimated 300 000 new cases of bladder cancer worldwide are diagnosed annually. Although new cytotoxic… 
Highly Cited
2007
Highly Cited
2007
Prognostic accuracy of an artificial neural network in patients undergoing radical cystectomy for bladder cancer: a comparison with logistic regression analysis
To compare the prognostic performance of an artificial neural network (ANN) with that of standard logistic regression (LR), in… 
2007
2007
Trastuzumab (T) combined with standard chemotherapy in HER+ metastatic bladder cancer (BC) patients: Interim safety results of a prospective randomized phase II study
15565 Background: Almost 25% of BC patients overexpressed HER2 and 50 to 60% of them are responding to the combination of T with… 
1981
1981
A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma.
Highly Cited
1980
Highly Cited
1980
Chemotherapy of Metastatic Bladder Cancer
Recent disease‐oriented phase II clinical trials in advanced transitional cell carcinoma of the urothelial tract have defined the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)